Join to View Full Profile
20 York StNew Haven, CT 06510
Phone+1 203-688-4242
Dr. Gueble is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterResidency, Radiation Oncology, 2019 - 2023
Yale School of MedicineClass of 2018
Certifications & Licensure
CT State Medical License 2018 - 2025
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma.Matthew McCord, Thomas Sears, Wenxia Wang, Rahul Chaliparambil, Shejuan An
Neuro-Oncology. 2025-03-07 - Development of Syngeneic Murine Glioma Models with Somatic Mismatch Repair Deficiency to Study Therapeutic Responses to Alkylating Agents and Immunotherapy.Deepti Bhatt, Ranjini K Sundaram, Karla S Lugo López, Teresa Lee, Susan E Gueble
Current Protocols. 2025-02-01 - 1 citationsMechanism of Action of KL-50, a Candidate Imidazotetrazine for the Treatment of Drug-Resistant Brain Cancers.Eric D Huseman, Anna Lo, Olga Fedorova, James L Elia, Susan E Gueble
Journal of the American Chemical Society. 2024-07-10
Grant Support
- Therapeutic Potential of a Novel MGMT-Dependent DNA Interstrand Crosslinking Agent in the Treatment of DNA Repair Deficient CancerYALE UNIVERSITY2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
